Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
18-24 patients will be included in the clinical Phase I/II study. Results from the Phase I part are expected in first half of 2013. Principal...
L'approbation de l'Agence norvégienne des médicaments (NOMA) de débuter l'étude clinique de phase I/II en Norvège a été reçue en novembre, et le...
Die Genehmigung der norwegischen Behörde für Arzneimittel (NOMA) für die Durchführung einer klinischen Studie der Phase I/II in Norwegen wurde im...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.